Iran's Supreme Leader Ayatollah Ali Khamenei: Since September, Iran has issued a warning to the Assad government about the threat, but it has ignored the "enemy".Jinfei Kaida: The controlling shareholder plans to increase the company's shares by 50 million yuan to 100 million yuan. Jinfei Kaida announced that the controlling shareholder Jinfei Holdings plans to increase the company's shares by 50 million yuan to 100 million yuan. Jinhua Branch of China Construction Bank Co., Ltd. issued the "China Construction Bank Loan Commitment Letter" to Jinfei Holdings on December 10th, promising to provide Jinfei Holdings with a special loan of no more than 90 million yuan for stock increase, with a loan period of 3 years.Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.
The China Securities Association held a plenary meeting of the professional committee on securities brokerage, wealth management and asset management, which was held in Beijing on December 3rd. The meeting stressed that the securities industry should focus on its main business, optimize supply, improve its value creation ability, form a diversified financial product and service system suitable for the needs of various investors, and implement the strategic layout of "five big articles"; Adhere to the customer-centered, practice the development concept of finance serving the country and finance serving the people, and correctly handle the relationship between functionality and profitability; Actively serve the national strategic needs, optimize product design, innovate service models, and provide more long-term financial support for the real economy. The meeting summarized the key work of the Committee in 2024 and discussed the work plan for 2025. In the next stage, the Committee will further play its role as a platform for communication, deliberation and handling affairs, unite industry consensus, guide the industry to focus on its main business, give full play to the functions of wealth managers, continuously improve its professional service capabilities, provide full chain services for investors' property preservation and appreciation, and help the high-quality development of the capital market.US officials said that the United States is focused on providing Ukraine with the air defense system it needs to defend against Russian missiles and drones.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Wanfang Development: A supplementary agreement on equity transfer of RMB 12.3 million was signed, and Wanfang Development announced that the company held the 66th meeting of the 9th Board of Directors on December 11th, 2024, at which the Proposal on the Progress of Selling a wholly-owned subsidiary and Signing a Supplementary Agreement was reviewed and approved. The Company signed Supplementary Agreement III to the Equity Transfer Agreement with Beijing Tianyuan and Beijing Baiyu, and Beijing Baiyu will pay the remaining equity transfer amount of RMB 12.3 million to the Company before December 31, 2025. As of the disclosure date of the announcement, Beijing Baiyu has paid 77.7 million yuan of equity transfer to the company, and the remaining 12.3 million yuan of equity transfer has not been paid. The company has transferred its 86.3333% equity of Beijing Tianyuan to Beijing Baiyu, so far, the company holds 13.6667% equity of Beijing Tianyuan.At the opening of the night session, the main contract of No.20 glue rose by nearly 2%, and the main contracts of low sulfur fuel oil (LU) and coking coal rose by over 1%. In terms of decline, the main contract of alumina fell by more than 1%, and the main contract of palm oil and soybean meal fell by nearly 1%.The minimum acceptable price of the two-year national debt issued by the Ministry of Finance in Hong Kong is 100.62 yuan. The minimum acceptable price of the five-year national debt issued by the Ministry of Finance in Hong Kong is 102.41 yuan.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14